Appearance:
White to off-white crystalline powder
Molecular Weight:
608.17
Boiling Point:
750.5°Cat760mmHg
Flash Point:
407.7°C
Usage:
A selective leukotriene D4-receptor antagonist. Used as an antiasthmatic
*The following content is generated by AI and is for reference only.
Overview
Montelukast Sodium Amorphous is the non-crystalline form of the leukotriene receptor antagonist used in asthma management. Synthesized via sodium salt formation followed by amorphization to enhance solubility, its molecular formula is C25H22ClNO4SNa and CAS No. is 160978-94-5.
Application
- Pharmaceutical manufacturing for prophylaxis of chronic asthma.
- Treatment of exercise-induced bronchoconstriction (EIB).
- Management of allergic rhinitis symptoms.
Precautions
Store under controlled conditions below 25°C with low humidity protection. Avoid use in acute bronchospasm attacks due to slow onset. Monitor for neuropsychiatric events as per FDA safety warnings.